Pneumonia survival depends heavily on age, with mortality climbing steeply after 65. Among hospitalized adults in one large study, the death rate was about 7% for those aged 18 to 64, roughly 16% for those 65 to 84, and close to 30% for those 85 and older. But age alone does not tell the full story: frailty, chronic illness, the type of pneumonia, and whether someone was vaccinated all shift the odds in ways that sometimes matter more than the birth date on a chart.
How Mortality Rates Change With Each Age Group
The sharpest dividing line in pneumonia survival is age 65. A study of adults hospitalized with pneumonia in Singapore found mortality rates of 7.3% among those aged 18 to 64, 16.1% among those 65 to 84, and 29.7% among those 85 and older.1PubMed Central. Prognostic factors for mortality due to pneumonia among adults from different age groups in Singapore and mortality predictions based on PSI and CURB-65 That pattern, where risk roughly doubles with each jump into an older bracket, shows up repeatedly in pneumonia research across countries. A separate U.S. study confirmed that mortality risk increased with age and with the burden of chronic conditions, and that readmission risk was highest for people aged 65 to 74 and those with high-risk health profiles.2PubMed. Mortality and readmission in the year following hospitalization for pneumonia among US adults
For patients over 75, one hospital-based study in Europe reported an in-hospital mortality of about 30%.3PubMed. Pneumonia mortality, comorbidities matter? These figures reflect the reality of pneumonia as it presents in hospitals, where patients tend to be sicker than those managed at home. Younger adults with pneumonia treated on an outpatient basis, by contrast, rarely die from it; mortality in that group is well under 1%.
It is worth noting that these numbers represent short-term, in-hospital or 30-day mortality. They do not capture the longer-term toll, which can be substantial, especially in older adults.
Pneumonia in Children Under Five
Among young children, pneumonia remains one of the leading infectious causes of death worldwide, but in countries with good healthcare access, most children survive. The risk factors that predict poor outcomes in this age group are different from those in adults. A study of children under five with acute pneumonia found that survival was influenced by age within the group itself: infants aged 1 to 11 months actually had better survival outcomes than children aged 48 to 59 months, possibly because older toddlers who develop severe pneumonia tend to have more complicated underlying conditions by the time they are hospitalized.4PubMed Central. Time to death and its predictors among under-five children with acute pneumonia: a Bayesian parametric survival analysis
Severe acute malnutrition, anemia, and low weight were all associated with faster death in children with pneumonia, as were being born outside a healthcare facility and having additional health conditions.4PubMed Central. Time to death and its predictors among under-five children with acute pneumonia: a Bayesian parametric survival analysis In well-resourced settings, childhood pneumonia mortality is low. But in regions where malnutrition is common and healthcare access is limited, the picture changes dramatically. Children with disabilities face disproportionate risk as well. In one Australian cerebral palsy registry, pneumonia was responsible for an estimated 40% of all deaths, and respiratory problems including daily cough, obstructive sleep apnea, and aspiration risk were widespread in that population.5European Respiratory Society (Breathe). Respiratory illness in children with disability: a serious problem?
Why Older Adults Are So Vulnerable
The steep rise in pneumonia deaths after age 65 is not just about the lungs aging. The immune system weakens with age in ways that specifically undermine the body’s ability to fight respiratory infections. Local immune defenses in the airways are essential for controlling bacteria that colonize the nose and throat, preventing those bacteria from spreading into the lungs. Age-related immune decline weakens these defenses, allowing pathogens to gain a foothold more easily and invade more aggressively.6The Lancet Respiratory Medicine. Pneumococcal colonisation and invasive pneumococcal disease in older adults
On top of immune decline, older adults are more likely to have chronic illnesses, take medications that suppress immune function, and have weaker cough reflexes, making them more prone to aspirating food or saliva into the lungs. These factors compound each other in ways that make the effective risk for any individual older adult hard to estimate from age alone.
Frailty Can Matter More Than Age
One of the more important findings in recent pneumonia research is that frailty, the overall state of physical reserve and resilience, predicts death from pneumonia at least as well as age does, and sometimes better. Among older pneumonia patients, mortality ranged from about 12% in those classified as not frail to over 45% in those classified as severely frail, even after adjusting for how severe the pneumonia itself was.7Journal of the American Medical Directors Association. Comparison of a Frailty Index With CURB-65 and Pneumonia Severity Index in Predicting Mortality and Persistent Disability After Pneumonia in Older Adults In another study focusing on geriatric patients, being severely frail was an independent risk factor for death with a dramatically elevated odds ratio, even when controlling for the standard clinical severity scores doctors use to triage pneumonia cases.8PubMed Central. Pneumonia in Geriatric Patients and Prediction of Mortality Based on the Pneumonia Severity Index (PSI), CURB-65, Frailty Index (FI), and FI-Lab21 Scores
This means two 80-year-olds admitted with the same type of pneumonia can have wildly different survival odds depending on how independently they were functioning before they got sick. A fit, active 82-year-old has a much better prognosis than a sedentary, dependent 75-year-old. Standard severity scores used in emergency departments account for age, confusion, blood pressure, and kidney function, but they miss frailty. Some researchers argue that adding a frailty assessment would improve how well doctors predict who is most at risk.
Aspiration Pneumonia Carries Higher Risk
Not all pneumonia is the same, and the type matters for survival. Aspiration pneumonia, which occurs when food, liquid, or saliva is inhaled into the lungs, is far more common in older adults and carries a worse prognosis than standard community-acquired pneumonia. In one study of older inpatients, 30-day mortality was 31% for aspiration pneumonia compared to 15% for non-aspiration pneumonia and 11% for the rest of the hospital cohort. Two years out, 69% of aspiration pneumonia patients had died, compared to 56% of those with other types of pneumonia.9PubMed. Long-Term Survival After Aspiration Pneumonia in Older Inpatients: A Comparative Study Even after adjusting for confounding factors, aspiration pneumonia remained significantly associated with both short-term and long-term death.
A separate study found that patients with community-acquired aspiration pneumonia were older, had more severe disease, and were more likely to need mechanical ventilation than those with regular community-acquired pneumonia. Their 30-day mortality was significantly higher as well.10PubMed Central. Mortality, morbidity, and disease severity of patients with aspiration pneumonia Among older adults with a median age of 84, those initially diagnosed with aspiration pneumonia had a median survival time of just 62 days, compared to 274 days for those with non-aspiration pneumonia.11PubMed Central. Prognostic factors of poor outcomes in pneumonia in older adults: aspiration or frailty?
Aspiration pneumonia is especially common in people with swallowing difficulties caused by stroke, dementia, Parkinson’s disease, or prolonged bed rest. Because these conditions also overlap heavily with frailty and advanced age, untangling how much of the excess mortality comes from the aspiration itself versus the underlying health state is difficult. But the clinical reality is clear: if you hear that an elderly relative has aspiration pneumonia rather than regular pneumonia, the prognosis is meaningfully worse.
Which Chronic Conditions Change the Outlook
Comorbidities are one of the strongest modifiers of pneumonia survival at every age, and the specific conditions that matter may surprise you. One large study found that living in a care facility, having chronic kidney disease, lung cancer, metastatic disease, mobility impairment, cachexia, dementia, cerebrovascular disease, or ischemic heart disease all increased the risk of dying from pneumonia. Notably, diabetes, obesity, COPD, and tobacco smoking were not independently associated with increased in-hospital pneumonia mortality in that analysis.3PubMed. Pneumonia mortality, comorbidities matter? That finding challenges a common assumption: while COPD and smoking certainly raise your risk of developing pneumonia in the first place, they may not independently raise your risk of dying from it once hospitalized, after accounting for other health factors.
Heart disease deserves special mention. Among elderly COPD patients with pneumonia, those with prior cardiovascular disease had consistently higher mortality at every time point. The gap widened over time: a 1% difference in death rates at 30 days grew to nearly 5% at one year.12PubMed Central. Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia This suggests that the cardiovascular stress of fighting pneumonia, including inflammation, fluid shifts, and increased cardiac demand, takes a long-term toll on hearts that were already compromised.
The number of comorbidities a person has matters independently of which specific conditions they are. In a large cross-sectional study, the probability of both developing pneumonia and dying from it rose with the number of coexisting conditions, in addition to the effect of age.13Journal of Preventive Medicine and Public Health. Association of Comorbidities With Pneumonia and Death Among COVID-19 Patients in Mexico: A Nationwide Cross-sectional Study The accumulation of conditions matters, not just the presence of any single one.
What Happens When Pneumonia Requires the ICU
Severe pneumonia that lands a patient in the intensive care unit is a different disease from the pneumonia treated on a regular hospital ward. ICU-level pneumonia carries a mortality rate of roughly 24%, and overall hospital mortality for those patients reaches about 30%.14Journal of Taibah University Medical Sciences. Severe pneumonia requiring ICU admission: Revisited These rates apply regardless of whether the pneumonia was acquired in the community or in the hospital.
Hospital-acquired pneumonia, which develops during a hospital stay for another reason, carries an additional layer of risk. One study found that hospital-acquired pneumonia had nearly three times the 28-day mortality hazard compared to community-acquired pneumonia after adjusting for other factors.15PubMed Central. Bacterial etiology and mortality rate in community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia in Thai university hospital The reasons include exposure to resistant bacteria, the fact that the patient was already sick enough to be hospitalized, and the use of devices like ventilators that create direct pathways for bacteria to enter the lungs.
Long-Term Survival After the Acute Episode
Surviving the hospital stay is only part of the story. Pneumonia appears to leave a lasting imprint on health, and long-term mortality after a pneumonia episode is higher than most people expect. In one population-based follow-up of elderly patients who survived community-acquired pneumonia, 89% were alive one year later, 80% at two years, 60% at five years, and only 39% at ten years. Among those who had been treated in the hospital specifically, the numbers were grimmer: 81% alive at one year, 68% at two years, 46% at five years, and 26% at ten years.16JAMA Internal Medicine. Prognosis After Community-Acquired Pneumonia in the Elderly: A Population-Based 12-Year Follow-up Study
These long-term numbers partly reflect the fact that people who get pneumonia tend to be less healthy to begin with, so their subsequent death rates would be higher even without the pneumonia. But research consistently shows that pneumonia itself appears to accelerate decline. Multiple risk factors, including age, sex, comorbidities, the type of pneumonia, and how severe the illness was, are all associated with higher long-term mortality after the acute episode has resolved.17PubMed Central. Long-term prognosis in community-acquired pneumonia For older adults especially, a bout of pneumonia often marks a turning point rather than a temporary setback.
Vaccination Makes a Measurable Difference
One of the most actionable findings in pneumonia research involves prevention. Among hospitalized adults with community-acquired pneumonia, those who had previously received a pneumococcal vaccine were half as likely to die during their hospital stay compared to unvaccinated patients, even after adjusting for age, smoking, comorbidities, and flu vaccination status.18Clinical Infectious Diseases. Prior Pneumococcal Vaccination Is Associated with Reduced Death, Complications, and Length of Stay among Hospitalized Adults with Community-Acquired Pneumonia That is a striking effect for a single preventive measure.
The benefit grows when both the pneumococcal and influenza vaccines are given together. A meta-analysis found that dual vaccination was associated with a roughly 17% lower pneumonia rate and a 23% lower all-cause mortality rate compared to influenza vaccination alone.19PubMed Central. Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysis A separate large cohort study of elderly individuals found a 27% decrease in mortality among those who received both vaccines, compared to 16% with influenza vaccination alone, suggesting the two vaccines provide additive protection.20PubMed Central. Additive preventive effect of influenza and pneumococcal vaccines in the elderly: results of a large cohort study
Despite this evidence, vaccination rates among older adults remain far below where they should be. Social determinants of health, including income, insurance status, and access to primary care, contribute to disparities in both vaccine uptake and pneumonia outcomes across racial and socioeconomic groups.21Scientific Reports. Demographic and regional trends of pneumonia mortality in the United States, 1999 to 2022
How Far We Have Come From the Pre-Antibiotic Era
The numbers discussed so far, while sobering for older adults, represent an enormous improvement over historical norms. Before effective antibiotics were available, pneumonia killed more than 30% of patients across all ages. By the mid-1950s, mortality had fallen below 10% in the general population thanks to antibiotics, though deaths continued to occur frequently among infants, the elderly, and those whose treatment was delayed.22JAMA Internal Medicine. TREATMENT OF BACTERIAL PNEUMONIA That 1955 observation, that the very young and very old remained vulnerable even with antibiotics, still holds today. The gap has narrowed, but it has not closed.
The modern challenge is less about the availability of antibiotics and more about antibiotic resistance, the aging of the population, and the growing number of people living with multiple chronic conditions. The pool of people most vulnerable to pneumonia is larger than ever, even as the treatments available are better than they have ever been.
Cognitive Decline After Pneumonia
Survival is not the only outcome that matters. A growing body of research suggests that hospitalization for pneumonia can leave lasting effects on thinking and memory. In a prospective study of adults hospitalized for community-acquired pneumonia, moderate-to-severe cognitive impairment was found in about a third of patients aged 65 and older at both 2 months and 12 months after discharge. Even among patients younger than 65, roughly 20% showed moderate-to-severe cognitive impairment a year later, and another third of all survivors had mild impairment.23PubMed Central. Long-Term Cognitive Impairment after Hospitalization for Community-Acquired Pneumonia: a Prospective Cohort Study Most of these patients had no evidence of cognitive problems before their pneumonia hospitalization.
Whether pneumonia itself causes dementia in the long run is less clear. A longitudinal study that tracked older adults for seven years found a slightly higher rate of dementia among those who had experienced pneumonia, but the difference was not statistically significant after adjusting for other factors.24PubMed Central. Impact of Pneumonia on Cognitive Aging: A Longitudinal Propensity-Matched Cohort Study The current best interpretation is that severe illness and hospitalization can cause lasting cognitive damage, particularly in older adults, but pneumonia may not carry a unique risk above and beyond other serious infections or hospitalizations. For families of older adults recovering from pneumonia, this means that some degree of confusion or memory difficulty in the weeks and months after discharge is common and does not necessarily signal the onset of dementia, though it warrants monitoring.